Locoregionally Advanced, BRAF V600L-Positive, Mucosal Melanoma of the Hypopharynx Treated With a Combination of BRAF and MFK Inhibitors

被引：0
|
作者：
Lampasona, Giovanni [1 ]
Noujaim, Jonathan [2 ]
Gologan, Olga [3 ]
Berdugo, Jeremie [4 ]
Maniakas, Anastasios [5 ,6 ,7 ]
机构：
[1] Sherbrooke Univ, Fac Med, Sherbrooke, PQ, Canada
[2] Hop Maison Neuve Rosemont, Dept Oncol, Montreal, PQ, Canada
[3] Montreal Univ Hosp Ctr, Dept Pathol, Montreal, PQ, Canada
[4] Hop Maison Neuve Rosemont, Dept Pathol, Montreal, PQ, Canada
[5] Hop Maison Neuve Rosemont, Div Otolaryngol Head & Neck Surg, Montreal, PQ, Canada
[6] McGill Univ, Dept Expt Surg, Montreal, PQ, Canada
[7] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, 1515 Holcombe Blvd,Unit 1445, Houston, TX 77030 USA
来源：
JCO PRECISION ONCOLOGY | 2022年 / 6卷
关键词：
CHEMOTHERAPY; MUTATIONS; THERAPY;
D O I：
10.1200/PO.21.00561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 28 条
  • [1] Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
    Al Hashmi, Muna
    Konduru, Seetharama S.
    Silcock, Lee
    Chouchane, Lotfi
    Mattei, Valentina
    James, Nicola
    Mathew, Rebecca
    Bedognetti, Davide
    De Giorgi, Valeria
    Murtas, Daniela
    Liu, Wei
    Chouchane, Aouatef
    Temanni, Ramzi
    Seliger, Barbara
    Wang, Ena
    Marincola, Francesco M.
    Tomei, Sara
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [2] Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
    Banzi, Maria
    De Blasio, Simona
    Lallas, Aimilios
    Longo, Caterina
    Moscarella, Elvira
    Alfano, Roberto
    Argenziano, Giuseppe
    ONCOTARGETS AND THERAPY, 2016, 9 : 2725 - 2733
  • [3] The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence
    Lemech, Charlotte
    Infante, Jeffrey
    Arkenau, Hendrik-Tobias
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (02) : 61 - 73
  • [4] Vemurafenib in Patients With BRAF V600E Mutation-Positive Advanced Melanoma
    Ravnan, Marcus C.
    Matalka, Mazen S.
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1474 - 1486
  • [5] BRAF Inhibitors and Radiation Do Not Act Synergistically to Inhibit WT and V600E BRAF Human Melanoma
    Walter, Lisa
    Heinzerling, Lucie
    ANTICANCER RESEARCH, 2018, 38 (03) : 1335 - 1341
  • [6] Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma
    Krepler, Clemens
    Xiao, Min
    Samanta, Minu
    Vultur, Adina
    Chen, Hsin-Yi
    Brafford, Patricia
    Reyes-Uribe, Patricia I.
    Halloran, Molly
    Chen, Thomas
    He, Xu
    Hristova, Denitsa
    Liu, Qin
    Samatar, Ahmed A.
    Davies, Michael A.
    Nathanson, Katherine L.
    Fukunaga-Kalabis, Mizuho
    Herlyn, Meenhard
    Villanueva, Jessie
    ONCOTARGET, 2016, 7 (44) : 71211 - 71222
  • [7] Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab
    Moser, Justin C.
    Chen, Danli
    Hu-Lieskovan, Siwen
    Grossmann, Kenneth F.
    Patel, Shiven
    Colonna, Sarah, V
    Ying, Jian
    Hyngstrom, John R.
    CANCER MEDICINE, 2019, 8 (18): : 7637 - 7643
  • [8] BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors
    Mandala, Mario
    Palmieri, Giuseppe
    Ludovini, Vienna
    Baglivo, Sara
    Marasciulo, Francesca
    Castiglione, Francesca
    Gili, Alessio
    Abate, Simona Osella
    Rubatto, Marco
    Senetta, Rebecca
    Avallone, Gianluca
    Ribero, Simone
    Romano, Luca
    Pimpinelli, Nicola
    de Giorgi, Vincenzo
    Roila, Fausto
    Pisano, Marina
    Casula, Milena
    Manca, Antonella
    Sini, Maria Cristina
    Massi, Daniela
    Quaglino, Pietro
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : 1991 - 1998
  • [9] Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma
    Tang, Hsin-Chieh
    Chen, Yu-Chian
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 3131 - 3146
  • [10] Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors
    Kahn, Adriana M.
    Perry, Curtis J.
    Etts, Katrina
    Kluger, Harriet
    Sznol, Mario
    ONCOLOGIST, 2024, 29 (04): : e507 - e513
123